The percentage of MMP9 protein bound to its inhibitor was low in all cases, with 5% of MMP9 bound to TIMP-1 in GBM on average, twice what was observed in controls and grade III (2.7% and 2.4%, respectively) (Fig. 6B). This evidence concerns the gene TIMP1 and glioblastoma.